Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.

Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check4 days agoChange DetectedAdded a new revision tag: Revision: v3.5.5, replacing Revision: v3.5.4. This update reflects a small revision history change for the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag at the bottom of the page updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page reflects small non-study informational updates, including resource/glossary labeling and a software/version revision change from v3.5.2 to v3.5.3. No substantive changes to the trial’s core study content (like eligibility criteria, interventions, or outcome measures) are indicated.SummaryDifference0.2%

- Check54 days agoChange DetectedA new revision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRemoved non-core items: the term 'Interstitial lung disease 2' and the Genetics and Rare Diseases Information Center resource link. These deletions do not affect the study's main data, eligibility criteria, or reported results.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0, indicating an update to the document set.SummaryDifference0.1%

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.